Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnholsúði, lausn - 16,2 mg/ml

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

heilsa ehf. - flurbiprofenum inn - munnsogstafla - 8,75 mg

Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - veirueyðandi lyf til almennrar notkunar - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - fluconazolum inn - innrennslislyf, lausn - 2 mg/ml

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - fluconazolum inn - hart hylki - 150 mg

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fluconazolum inn - hart hylki - 150 mg

Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fluconazolum inn - hart hylki - 200 mg